Free Trial

Captrust Financial Advisors Purchases New Position in Everus (NYSE:ECG)

Everus logo with Construction background

Captrust Financial Advisors acquired a new stake in Everus (NYSE:ECG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 52,720 shares of the company's stock, valued at approximately $3,466,000. Captrust Financial Advisors owned 0.10% of Everus at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of ECG. SRS Capital Advisors Inc. purchased a new stake in shares of Everus during the 4th quarter valued at about $26,000. Principal Securities Inc. purchased a new stake in shares of Everus during the fourth quarter valued at approximately $27,000. HighMark Wealth Management LLC acquired a new position in shares of Everus during the fourth quarter worth $28,000. Crews Bank & Trust purchased a new position in shares of Everus in the fourth quarter valued at $29,000. Finally, Mendota Financial Group LLC acquired a new stake in Everus during the 4th quarter valued at $36,000.

Everus Stock Down 0.5 %

ECG opened at $48.02 on Friday. Everus has a 12-month low of $31.38 and a 12-month high of $77.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58. The company has a fifty day moving average of $39.31.

Everus (NYSE:ECG - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, research analysts predict that Everus will post 2.49 EPS for the current year.

Insider Activity at Everus

In related news, Director Edward A. Ryan acquired 1,400 shares of the stock in a transaction that occurred on Tuesday, February 25th. The stock was purchased at an average cost of $38.02 per share, for a total transaction of $53,228.00. Following the purchase, the director now directly owns 14,928 shares in the company, valued at $567,562.56. This represents a 10.35 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Rocca Michael Della bought 1,050 shares of the business's stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $47.56 per share, for a total transaction of $49,938.00. Following the completion of the purchase, the director now directly owns 2,027 shares of the company's stock, valued at $96,404.12. The trade was a 107.47 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 3,750 shares of company stock valued at $153,853. Corporate insiders own 0.21% of the company's stock.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus decreased their price objective on shares of Everus from $67.00 to $55.00 and set a "buy" rating for the company in a research report on Wednesday, April 9th.

Read Our Latest Research Report on ECG

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Recommended Stories

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG - Free Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Everus Right Now?

Before you consider Everus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Everus wasn't on the list.

While Everus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines